AKT1 and Hyperglycemia: Previous studies have shown that AKT-null mice have hyperglycemia and loss of β-cell mass with increased levels of apoptosis [18], whereas overexpression of a constitutively active AKT in β-cells lead to an increase in islet mass and β-cell proliferation [19].